Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.65 |
| ▸ | HPGD | P15428 | 5/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.65 |
| ▸ | MEN1 | O00255 | 3/20 | 0.65 |
| ▸ | STAT3 | P40763 | 1/20 | 0.65 |
| ▸ | STAT1 | P42224 | 1/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.65 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.65 |
| ▸ | SCD5 | Q86SK9 | 1/20 | 0.64 |
| ▸ | POLB | P06746 | 1/20 | 0.63 |
| ▸ | HTT | P42858 | 1/20 | 0.60 |
| ▸ | RAB9A | P51151 | 3/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.60 |
| ▸ | NPC1 | O15118 | 3/20 | 0.60 |
| ▸ | LMNA | P02545 | 2/20 | 0.60 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 5/20 | 0.59 |
| ▸ | GAA | P10253 | 1/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3671813 | 0.82 | ROCK2 (0.62) | HSD17B10HPGDKMT2AMEN1ALDH1A1 | |
| SCHEMBL13902156 | 0.81 | MAPT (0.88) | HSD17B10HPGDKMT2AMEN1ALDH1A1 | |
| SCHEMBL12349839 | 0.79 | RAB9A (0.76) | HSD17B10HPGDKMT2AALDH1A1KDM4E | |
| SCHEMBL21523613 | 0.78 | SCD5 (1.00) | HSD17B10HPGDKMT2AMEN1ALDH1A1 | |
| SCHEMBL17788443 | 0.78 | HIF1A (0.68) | HPGDKMT2AALDH1A1POLBRAB9A | |
| SCHEMBL18619857 | 0.78 | MAPT (0.67) | HSD17B10HPGDKMT2AMEN1ALDH1A1 | |
| SCHEMBL5031873 | 0.77 | POLB (0.53) | HSD17B10HPGDKMT2AMEN1STAT3 | |
| SCHEMBL17652545 | 0.77 | HIF1A (0.67) | HSD17B10HPGDKMT2ASTAT3STAT1 | |
| SCHEMBL68906 | 0.76 | HIF1A (0.70) | HPGDKMT2AMEN1ALDH1A1RAB9A | |
| SCHEMBL12349834 | 0.76 | TP53 (0.78) | HPGDKMT2AALDH1A1POLBHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 224 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260102351-A1 | LYOPHILIZED FORMULATION OF CROFELEMER AND METHODS OF TREATMENT USING THE SAME | NAPO PHARMACEUTICALS INC (US) | 2026-04-16 | — | — | US | claimed |
| EP-4633622-A2 | COMPOSITIONS AND METHODS FOR REGULATING PROCOAGULANT ACTIVITY AND THROMBOSIS | Beth Israel Deaconess Medical Center, Inc. (US) | 2025-10-22 | — | — | EP | claimed |
| EP-4593816-A2 | LYOPHILIZED FORMULATION OF CROFELEMER AND METHODS OF TREATMENT USING THE SAME | Napo Pharmaceuticals, Inc. (US) | 2025-08-06 | — | — | EP | claimed |
| US-20240325346-A1 | METHODS AND COMPOSITIONS FOR TREATING CONGENITAL DIARRHEA DISORDER | NAPO PHARMACEUTICALS INC (US) | 2024-10-03 | — | — | US | claimed |
| US-20240282425-A1 | AUTHENTICATION METHODS AND SYSTEMS FOR DISPENSED PRESCRIPTIONS | LOW GORDON KEITH (US) | 2024-08-22 | — | — | US | claimed |
| US-12064443-B2 | Compositions and methods for treating diseases associated with drug washout due to fluid secretion | VANESSA RESEARCH HOLDINGS, INC. (US) | 2024-08-20 | — | — | US | claimed |
| EP-4408480-A1 | COMPOSITIONS AND METHODS FOR METAL CONTAINING FORMULATIONS CAPABLE OF MODULATING IMMUNE RESPONSE | The Regents Of The University Of Michigan (US) | 2024-08-07 | — | — | EP | claimed |
| EP-3634581-B1 | COMPOSITIONS FOR USE IN TREATING CONGENITAL DIARRHEA DISORDER | NAPO PHARMACEUTICALS INC (US) | 2024-07-31 | — | — | EP | claimed |
| EP-3634455-B1 | COMPOSITIONS FOR TREATING BILE ACID DIARRHEA AND SHORT BOWEL SYNDROME | NAPO PHARMACEUTICALS INC (US) | 2024-07-03 | — | — | EP | claimed |
| WO-2024129758-A2 | COMPOSITIONS AND METHODS FOR REGULATING PROCOAGULANT ACTIVITY AND THROMBOSIS | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. (US) | 2024-06-20 | — | — | WO | claimed |
| EP-4294378-A1 | COMPOSITIONS AND METHODS FOR TREATING DISEASES ASSOCIATED WITH DRUG WASHOUT DUE TO FLUID SECRETION | Vanessa Research, Inc. (US) | 2023-12-27 | — | — | EP | claimed |
| US-20230398136-A1 | COMPOSITIONS AND METHODS FOR TREATING DISEASES ASSOCIATED WITH DRUG WASHOUT DUE TO FLUID SECRETION | VANESSA RESEARCH, INC. (US) | 2023-12-14 | — | — | US | claimed |
| EP-4168027-A1 | METHODS AND COMPOSITIONS FOR TREATING CHEMOTHERAPY-INDUCED DIARRHEA | Napo Pharmaceuticals, Inc. (US) | 2023-04-26 | — | — | EP | claimed |
| WO-2023056427-A1 | COMPOSITIONS AND METHODS FOR METAL CONTAINING FORMULATIONS CAPABLE OF MODULATING IMMUNE RESPONSE | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2023-04-06 | — | — | WO | claimed |
| US-20220362209-A1 | METHODS AND COMPOSITIONS FOR TREATING CHEMOTHERAPY-INDUCED DIARRHEA | NAPO PHARMACEUTICALS INC (US) | 2022-11-17 | — | — | US | claimed |
| EP-4061304-A1 | MULTI-CHAMBER CONTAINER | Rupprecht, Holger (DE) | 2022-09-28 | — | — | EP | claimed |
| WO-2022175899-A1 | COMPOSITIONS AND METHODS FOR TREATING DISEASES ASSOCIATED WITH DRUG WASHOUT DUE TO FLUID SECRETION | VANESSA RESEARCH, INC. (US) | 2022-08-25 | — | — | WO | claimed |
| US-11389424-B2 | Methods and compositions for treating chemotherapy-induced diarrhea | NAPO PHARMACEUTICALS, INC. (US) | 2022-07-19 | — | — | US | claimed |
| WO-2022115481-A1 | METHODS AND COMPOSITIONS FOR TREATING POST-ACUTE INFECTION GASTROINTESTINAL DISORDERS | NAPO PHARMACEUTICALS, INC. (US) | 2022-06-02 | — | — | WO | claimed |
| US-20220072023-A1 | COMPOSITIONS AND METHODS FOR METAL CONTAINING FORMULATIONS CAPABLE OF MODULATING IMMUNE RESPONSE | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2022-03-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220072023-A1 | COMPOSITIONS AND METHODS FOR METAL CONTAINING FORMULATIONS CAPABLE OF MODULATING IMMUNE RESPONSE | MYD88, STING1, TLR3 | HSD17B10 4846/4885HPGD 2039/4885KMT2A 4432/4885 |
| US-12064443-B2 | Compositions and methods for treating diseases associated with drug washout due to fluid secretion | SLC10A2, SI, SLC10A1 | HSD17B10 1728/4885HPGD 313/4885KMT2A 4576/4885 |
| US-20260102351-A1 | LYOPHILIZED FORMULATION OF CROFELEMER AND METHODS OF TREATMENT USING THE SAME | SBDS, SI, CLNS1A | HSD17B10 1226/4885HPGD 2330/4885KMT2A 2207/4885 |
| US-11389424-B2 | Methods and compositions for treating chemotherapy-induced diarrhea | SLC10A2, SLC26A3, SLC47A1 | HSD17B10 1798/4885HPGD 1986/4885KMT2A 2701/4885 |
| US-20230398136-A1 | COMPOSITIONS AND METHODS FOR TREATING DISEASES ASSOCIATED WITH DRUG WASHOUT DUE TO FLUID SECRETION | SLC10A2, SI, SLC10A1 | HSD17B10 1728/4885HPGD 313/4885KMT2A 4576/4885 |
| US-20240325346-A1 | METHODS AND COMPOSITIONS FOR TREATING CONGENITAL DIARRHEA DISORDER | DSC1, PCTP, SLC26A4 | HSD17B10 423/4885HPGD 667/4885KMT2A 4346/4885 |
| US-20220362209-A1 | METHODS AND COMPOSITIONS FOR TREATING CHEMOTHERAPY-INDUCED DIARRHEA | SLC10A2, SLC26A3, SLC47A1 | HSD17B10 1798/4885HPGD 1986/4885KMT2A 2701/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.